Monopar Therapeutics
MNPRNasdaqCIK 1645469HealthcareFiscal year ends Dec 31
Reports and events: 180 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-08-1408:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-026563 |
| 2024-08-0908:02 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001437749-24-025651 |
| 2024-08-0908:01 ET | 8-K | 2.02 Results of operations; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-24-025650 |
| 2024-07-2207:00 ET | DEF 14A | Proxy statementPeriod 2024-08-05 | 0001437749-24-023123 |
| 2024-07-0916:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-022403 |
| 2024-06-1107:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-019881 |
| 2024-06-1008:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-019747 |
| 2024-05-2408:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-018249 |
| 2024-05-0907:00 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001437749-24-015454 |
| 2024-05-0907:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-015453 |
| 2024-04-1608:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-012131 |
| 2024-04-1008:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-011573 |
| 2024-03-2807:01 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001437749-24-009687 |
| 2024-03-2807:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-009686 |
| 2024-03-0708:30 ET | 8-K | 7.01 Regulation FD disclosure | 0001437749-24-006900 |
| 2024-03-0507:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-006538 |
| 2024-02-2813:45 ET | 8-K | 3.01 Delisting notice | 0001437749-24-005871 |
| 2024-02-2706:59 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-005624 |
| 2024-02-2207:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-005127 |
| 2024-02-2008:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-004724 |
| 2023-11-0907:01 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001437749-23-031066 |
| 2023-11-0907:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-031065 |
| 2023-11-0107:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-029657 |
| 2023-08-3017:16 ET | 8-K | 3.01 Delisting notice | 0001437749-23-024891 |
| 2023-08-1007:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-022875 |
| 2023-08-1007:00 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001437749-23-022874 |
| 2023-08-0807:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-022388 |
| 2023-07-1107:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-019665 |
| 2023-06-2816:13 ET | 8-K | 5.07 Shareholder vote results | 0001437749-23-018753 |
| 2023-06-0107:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-23-007456 |
| 2023-05-1107:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-23-006120 |
| 2023-05-1107:01 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001654954-23-006119 |
| 2023-04-2816:18 ET | DEF 14A | Proxy statementPeriod 2023-06-27 | 0001654954-23-005414 |
| 2023-03-2717:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-23-003607 |
| 2023-03-2307:05 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001654954-23-003384 |
| 2023-03-2307:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-23-003383 |
| 2023-02-2707:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-23-002082 |
| 2023-02-1407:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-23-001634 |
| 2023-01-2607:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-23-000825 |
| 2023-01-1807:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-23-000519 |
| 2022-12-1207:26 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-22-016326 |
| 2022-11-1607:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-22-015397 |
| 2022-11-1008:01 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001654954-22-014939 |
| 2022-11-1008:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-22-014938 |
| 2022-10-0508:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-22-013366 |
| 2022-08-1108:12 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001654954-22-011015 |
| 2022-08-1108:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-22-011014 |
| 2022-06-3016:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001654954-22-009047 |
| 2022-05-1209:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-22-006509 |
| 2022-05-1209:41 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001654954-22-006507 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 18:09 ET. Listed shows no prices and gives no investment advice.